How did UCB close its $1.9 billion deal to buy Zogenix and its key epilepsy drug? SEC filing reveal details

How did UCB close its $1.9 billion deal to buy Zogenix and its key epilepsy drug? SEC filing reveal details
kdunleavy
Tue, 02/01/2022 – 16:53